John Butler | CEO, President & Director |
Jason Amello | SVP, CFO & Treasurer |
Michel Dahan | SVP & Chief Business Officer |
Douglas Jermasek | VP, Marketing & Strategy |
Rita Jain | SVP & Chief Medical Officer |
Christopher Raymond | Piper Jaffray Companies |
Kennen MacKay | RBC Capital Markets |
Difei Yang | Mizuho Securities |
Reni Benjamin | Raymond James & Associates |
Robert Hazlett | BTIG. |
Ishmael Asante | Morgan Stanley |
Chad Messer | Needham & Company |
Antonio Arce | H.C. Wainwright & Co. |
Good day, ladies and gentlemen, and welcome to the Akebia Therapeutics Preliminary Full-Year 2018 Financial Results and Business Highlights conference call.
As a reminder, this conference call is being recorded. [Operator Instructions]. I would now like to introduce your host for today's conference, Megan [ph]. The floor is yours.